490 related articles for article (PubMed ID: 32883310)
1. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.
Benencio P; Fraile Gonzalez SA; Ducasa N; Page K; Berini CA; Biglione MM
Retrovirology; 2020 Sep; 17(1):29. PubMed ID: 32883310
[TBL] [Abstract][Full Text] [Related]
2. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.
Jeffery KJ; Siddiqui AA; Bunce M; Lloyd AL; Vine AM; Witkover AD; Izumo S; Usuku K; Welsh KI; Osame M; Bangham CR
J Immunol; 2000 Dec; 165(12):7278-84. PubMed ID: 11120862
[TBL] [Abstract][Full Text] [Related]
3. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
[TBL] [Abstract][Full Text] [Related]
4. HLA-G 3'-untranslated region polymorphisms are associated with HTLV-1 infection, proviral load and HTLV-associated myelopathy/tropical spastic paraparesis development.
Cilião Alves DC; Haddad R; Rocha-Júnior MC; de Deus Wagatsuma VM; Martelli-Palomino G; Marques AA; Takayanagui OM; Covas DT; Kashima S; Donadi EA
J Gen Virol; 2016 Oct; 97(10):2742-2752. PubMed ID: 27449667
[TBL] [Abstract][Full Text] [Related]
5. HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions.
Tarokhian H; Rahimi H; Mosavat A; Shirdel A; Rafatpanah H; Akbarin MM; Bari A; Ramezani S; Rezaee SA
BMC Cancer; 2018 Dec; 18(1):1287. PubMed ID: 30577817
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between single-nucleotide polymorphisms of pro- and anti-inflammatory cytokines and HTLV-1-associated myelopathy / tropical spastic paraparesis development in patients from Rio de Janeiro, Brazil.
Schor D; Porto LC; Roma EH; Quintana MSB; Fabricio-Silva GM; Bonecini-Almeida MG; Araújo AQ; Andrada-Serpa MJ
BMC Infect Dis; 2018 Nov; 18(1):593. PubMed ID: 30466392
[TBL] [Abstract][Full Text] [Related]
7. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection.
Rafatpanah H; Pravica V; Faridhosseini R; Tabatabaei A; Ollier W; Poulton K; Thomson W; Hutchinson I
Iran J Immunol; 2007 Jun; 4(2):94-100. PubMed ID: 17652849
[TBL] [Abstract][Full Text] [Related]
8. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
[TBL] [Abstract][Full Text] [Related]
9. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
[TBL] [Abstract][Full Text] [Related]
10. Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.
Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Senitzer D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
Hum Immunol; 2010 Aug; 71(8):804-8. PubMed ID: 20483367
[TBL] [Abstract][Full Text] [Related]
11. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Vine AM; Witkover AD; Lloyd AL; Jeffery KJ; Siddiqui A; Marshall SE; Bunce M; Eiraku N; Izumo S; Usuku K; Osame M; Bangham CR
J Infect Dis; 2002 Oct; 186(7):932-9. PubMed ID: 12232833
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in HLA-C and KIR alleles are not associated with HAM/TSP risk in HTLV-1-infected subjects.
Assone T; Malta FM; Bakkour S; Montalvo L; Paiva AM; Smid J; de Oliveira ACP; de Toledo Gonçalves F; do Carmo Luiz O; Fonseca LAM; Norris PJ; Casseb J
Virus Res; 2018 Jan; 244():71-74. PubMed ID: 29129607
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Kodama D; Tanaka M; Matsuzaki T; Izumo K; Nakano N; Matsuura E; Saito M; Nagai M; Horiuchi M; Utsunomiya A; Takashima H; Kubota R; Izumo S
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008361. PubMed ID: 32667912
[TBL] [Abstract][Full Text] [Related]
15. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.
Jeffery KJ; Usuku K; Hall SE; Matsumoto W; Taylor GP; Procter J; Bunce M; Ogg GS; Welsh KI; Weber JN; Lloyd AL; Nowak MA; Nagai M; Kodama D; Izumo S; Osame M; Bangham CR
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3848-53. PubMed ID: 10097126
[TBL] [Abstract][Full Text] [Related]
16. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
[TBL] [Abstract][Full Text] [Related]
17. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients.
Talledo M; López G; Huyghe JR; Verdonck K; Adaui V; González E; Best I; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
J Med Virol; 2010 Mar; 82(3):460-6. PubMed ID: 20087941
[TBL] [Abstract][Full Text] [Related]
19. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
[TBL] [Abstract][Full Text] [Related]
20. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
